Jasmine Foo
Jasmine Foo
Associate Professor of Mathematics, University of Minnesota
確認したメール アドレス: umn.edu - ホームページ
タイトル
引用先
引用先
Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling
J Chmielecki, J Foo, GR Oxnard, K Hutchinson, K Ohashi, R Somwar, ...
Science translational medicine 3 (90), 90ra59-90ra59, 2011
4592011
The multi-element probabilistic collocation method (ME-PCM): Error analysis and applications
J Foo, X Wan, GE Karniadakis
Journal of Computational Physics 227 (22), 9572-9595, 2008
2442008
Multi-element probabilistic collocation method in high dimensions
J Foo, GE Karniadakis
Journal of Computational Physics 229 (5), 1536-1557, 2010
2152010
Evolution of acquired resistance to anti-cancer therapy
J Foo, F Michor
Journal of theoretical biology 355, 10-20, 2014
1512014
A physical sciences network characterization of non-tumorigenic and metastatic cells
TPSOC Network, DB Agus, JF Alexander, W Arap, S Ashili, JE Aslan, ...
Scientific reports 3, 1449, 2013
1112013
Intratumor heterogeneity in evolutionary models of tumor progression
R Durrett, J Foo, K Leder, J Mayberry, F Michor
Genetics 188 (2), 461-477, 2011
1102011
Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies
J Foo, F Michor
PLoS computational biology 5 (11), 2009
1052009
Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer
J Foo, J Chmielecki, W Pao, F Michor
Journal of Thoracic Oncology 7 (10), 1583-1593, 2012
822012
Evolution of resistance to anti-cancer therapy during general dosing schedules
J Foo, F Michor
Journal of theoretical biology 263 (2), 179-188, 2010
812010
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib
J Foo, MW Drummond, B Clarkson, T Holyoake, F Michor
PLoS computational biology 5 (9), 2009
662009
The impact of microenvironmental heterogeneity on the evolution of drug resistance in cancer cells
SM Mumenthaler, J Foo, NC Choi, N Heise, K Leder, DB Agus, W Pao, ...
Cancer informatics 14, CIN. S19338, 2015
652015
Vortex mode selection of a rigid cylinder subject to VIV at low mass-damping
D Lucor, J Foo, GE Karniadakis
Journal of Fluids and Structures 20 (4), 483-503, 2005
622005
Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia
K Leder, J Foo, B Skaggs, M Gorre, CL Sawyers, F Michor
PloS one 6 (11), e27682, 2011
522011
Evolutionary dynamics of tumor progression with random fitness values
R Durrett, J Foo, K Leder, J Mayberry, F Michor
Theoretical population biology 78 (1), 54-66, 2010
502010
Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs
J Shu, Z Xia, L Li, ET Liang, N Slipek, D Shen, J Foo, S Subramanian, ...
RNA biology 9 (10), 1275-1287, 2012
482012
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer
SM Mumenthaler, J Foo, K Leder, NC Choi, DB Agus, W Pao, P Mallick, ...
Molecular pharmaceutics 8 (6), 2069-2079, 2011
472011
Stochastic dynamics of cancer initiation
J Foo, K Leder, F Michor
Physical biology 8 (1), 015002, 2011
442011
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials
M Tang, J Foo, M Gönen, J Guilhot, FX Mahon, F Michor
Haematologica 97 (10), 1553-1561, 2012
382012
Stochastic simulation of riser-sections with uncertain measured pressure loads and/or uncertain material properties
J Foo, Z Yosibash, GE Karniadakis
Computer methods in applied mechanics and engineering 196 (41-44), 4250-4271, 2007
382007
Multifocality and recurrence risk: a quantitative model of field cancerization
J Foo, K Leder, MD Ryser
Journal of theoretical biology 355, 170-184, 2014
302014
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20